Avita Medical | 1811094D - Gewinn Vor Steuern

Aktienkurs
1.15
Täglich Wechseln
-0.02 -1.71%
Monatlich
-16.67%
Jährlich
-45.75%
Q2 Prognose
1.16




Gewinn Vor Steuern Veränderung Datum
Accuray USD 3.23M 6.56M 2024-12
Celltrion KRW 10.5B 4.1B 2025-12
Clinuvel Pharmaceuticals AUD 28.8M 6.9M 2025-06
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Medical Developments International AUD -149K 466K 2025-06
Nanosonics AUD 11.39M 487K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacific Edge NZD -714K 49K 2024-03
Pharma Mar EUR 1.6M 38.6M 2026-03
Polynovo AUD 1.96M 146K 2025-12
PYC Therapeutics AUD -12.57M 13.3M 2025-06
Qiagen NV USD 109.17M 25.56M 2025-12
Ramsay Health Care AUD 103.75M 54.35M 2025-06
ResMed USD 496.15M 13.77M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03